we're seeing you and other companies pulling back from the UK. You know, just last week saw that you were pausing um one of your investments there. So, what's happening in the UK and you know, should that send a message to policy makers here in the US.>> Probably it should. I mean, I think uh the UK has been on a a long slow glide path from a leader in biofarmaceuticals to really a lagard and that's happened over the last 20 years through a number of policy mistakes. Um the most important one is that their ...

特朗普的药品定价政策是对制药公司的重大打击 金十数据5月12日讯，Bryan Garnier Research的分析师在一份报告中表示，尽管不确定特朗普的"最惠 国"药品定价政策是否会在国会获得足够的政治支持，但这一政策对制药行业构成了威胁。分析人士 说，特朗普在2020年的第一个任期内推出了类似的政策，但被一名联邦法官阻止，最终在2021年被时任 总统拜登取消。他们说，目前还不清楚如果这项政策生效，医疗保险的哪些项目会受到影响。 ...